Chapter 71 – Chagas’ DiseaseJosé A.F. Ramires,
Andrei C. Sposito,
Edécio Cunha Neto,
Maria de Lourdes Higuchi
| | | PATHOLOGIC FINDINGS, 1611
|
| | | PATHOPHYSIOLOGY, 1611
|
| | | CLINICAL MANIFESTATIONS, 1614| | | Acute Phase, 1614
| | | | Indeterminate and Chronic Phases, 1615
|
|
| | | LABORATORY EVALUATION, 1615| | | Diagnosis, 1615
| | | | Echocardiography, 1615
| | | | Imaging Studies, 1615
|
|
| | | MANAGEMENT, 1615| | | Antitrypanosomal Drug Treatment, 1615
| | | | Concomitant Treatment, 1616
|
|
| | | CHAGAS’ DISEASE IN THE UNITED STATES, 1616
|
| | | REFERENCES, 1616
|
Chagas’ disease, or American trypanosomiasis, is an infection caused by the protozoan Trypanosoma cruzi (T. cruzi), originally transmitted by hematophagous triatomine insects.[1,2] Triatominae infected by T. cruziinhabit 18 countries in North and South America, ranging from the southern United States to southern Argentina, and the prevalence of the disease relates to the proximity between infected triatomines and humans. The infection can also result from maternal-fetal transmission, from food contaminated with feces or urine from infected …
